![](https://www.canaan.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBWjA9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--956c64aea933ed39ad9d85f18ce4f5369189f239/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9VWTI5dFltbHVaVjl2Y0hScGIyNXpld2M2QzNKbGMybDZaVWtpQ1RVeE1sNEdPZ1pGVkRvSmRISnBiVlE9IiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--227fdc48d0cc0381319025b1f375233c6a320fb3/esperiontherapeutics.png)
Esperion Therapeutics
Esperion is a biopharmaceutical company focused on the discovery and development of therapies for the treatment of cardiovascular disease. Esperion is now a division of Pfizer Global Research and Development.
Investment
Series C